May 31, 2022: U.S. Patent No. 11,344,246 "Long QT Syndrome Diagnosis and Classification"

Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,344,246 entitled, "Long QT Syndrome Diagnosis and Classification," on May 31, 2022 to Habib Alah Hajimolahoseini, Javad Hashemi, and Damian Redfearn. The patent relates to a method for detecting long QT syndrome in a subject comprises obtaining data corresponding to an electrocardiogram (ECG) signal of the subject, identifying a set of features in the data based on selected inflection points of the ECG signal, using the set of features to categorize segments of the ECG signal, and using the categorized segments of the ECG signal and the inflection points to classify the ECG signal as normal or as long QT syndrome.

U.S. Patent No. 11,344,246 (PDF, 900.4 KB)